Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Kymera Therapeutics Inc
KYMRCurrent price
41.96 USD
-3.99 USD (-8.67%)
Last closed
45.95 USD
Company
www.kymeratx.com
ISIN
US5015751044
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 299 792 128 USD
Yield for 12 month
+115.95 %
1Y
3Y
5Y
10Y
15Y
KYMR
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company develops STAT6, a Type 2 inflammation in allergic diseases; and TYK2, a treatment for inflammatory bowel disease, psoriasis, psoriatic arthritis, and lupus. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts. Address: 200 Arsenal Yards Boulevard, Watertown, MA, United States, 02472
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
57.44 USDP/E ratio
–Dividend Yield
–Current Year
+78 592 000 USD
Last Year
+46 826 000 USD
Current Quarter
+3 741 000 USD
Last Quarter
+25 650 000 USD
Current Year
+75 027 000 USD
Last Year
+43 849 000 USD
Current Quarter
+1 741 000 USD
Last Quarter
+23 750 000 USD
Key Figures KYMR
1 year
3 years
5 years
10 years
EBITDA
-190 490 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-15.38 %
PEG Ratio
–
Return On Equity TTM
-26 %
Wall Street Target Price
57.44 USD
Revenue TTM
87 563 000 USD
Book Value
13.79 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-20.9 %
Dividend Yield
–
Gross Profit TTM
-117 422 000 USD
Earnings per share
-2.34 USD
Diluted Eps TTM
-2.34 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-191.26 %
Dividend Analytics KYMR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History KYMR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation KYMR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
32.4041
Price Sales TTM
37.6848
Enterprise Value EBITDA
-9.4883
Price Book MRQ
3.6947
Financials KYMR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators KYMR
For 52 weeks
15.95 USD
53.27 USD
50 Day MA
47.06 USD
Shares Short Prior Month
8 807 131
200 Day MA
40.33 USD
Short Ratio
19.45
Shares Short
9 066 772
Short Percent
15.64 %
BeatStart